Market Place
Sourcing Support
Boundless Bio To Present Oral Kinesin Degrader Program At AACR
17 Mar 2026 //
GLOBENEWSWIRE
Boundless Bio To Join Leerink Global Healthcare Conference
04 Mar 2026 //
GLOBENEWSWIRE
Boundless Bio Reports Q2 2025 Financial Results and Business
05 Aug 2025 //
GLOBENEWSWIRE
Boundless Bio Lays Off 33% of Staff as Lead Program Stumbles
27 May 2025 //
FIERCE BIOTECH
Boundless Bio Reports Q1 2025 Financial Results and Highlights
09 May 2025 //
GLOBENEWSWIRE
Boundless Bio Reports Q4 and Full Year 2024 Financial Results
27 Mar 2025 //
GLOBENEWSWIRE
Boundless Bio Appoints Robert Doebele as Chief Medical Officer
03 Feb 2025 //
GLOBENEWSWIRE
Boundless Bio Makes `Modest` Layoffs Amid Sluggish Enrollment
13 Aug 2024 //
FIERCE BIOTECH
Boundless Bio: Participating At Goldman Sachs Healthcare Conference
05 Jun 2024 //
BUSINESSWIRE
Boundless Bio Reports Q1 2024 Financial Results, Highlights
13 May 2024 //
BUSINESSWIRE
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024
06 May 2024 //
BUSINESSWIRE
Boundless Bio Doses First Patient With BBI-825 In Phase 1/2
11 Apr 2024 //
BUSINESSWIRE
Boundless Bio Announces Pricing of Initial Public Offering
27 Mar 2024 //
BUSINESSWIRE
Early-stage oncology startup Boundless Bio files for IPO
06 Mar 2024 //
ENDPTS
Boundless Bio bumps IPO market back to life
06 Mar 2024 //
FIERCE BIOTECH
Boundless Bio Announces Multiple Upcoming Presentations
05 Mar 2024 //
BUSINESSWIRE
Boundless Bio Announces Upcoming Presentations at 2023 AACR-NCI-EORTC
04 Oct 2023 //
BUSINESSWIRE
Boundless Bio Appoints New Board Members and Establishes Clinical Advisory Board
02 Oct 2023 //
BUSINESSWIRE
Boundless Announces Clinical Trial Collaboration and Supply Agreement with Lilly
19 Sep 2023 //
BUSINESSWIRE
Boundless Bio Announces Agreement with Taiho Oncology to Evaluate LYTGOBI
18 Sep 2023 //
BUSINESSWIRE
After EQRx stint,Jami Rubin quickly returns to CFO post at startup Boundless Bio
31 Jul 2023 //
ENDPTS
Boundless Bio Announces 1st Patient Dosed First-in-Human Ph1/2 Trial of BBI-355
09 May 2023 //
BUSINESSWIRE
Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days
11 Apr 2023 //
BUSINESSWIRE
Boundless Bio Announces Upcoming Presentation at AACR Meeting
15 Mar 2023 //
BUSINESSWIRE
Boundless Bio to Participate at Two Upcoming Investor Conferences
15 Nov 2022 //
BUSINESSWIRE
Boundless Bio Appoints Sara Weymer as Vice President, Clinical Operations
03 Jun 2022 //
BUSINESSWIRE
Boundless Bio Announces Upcoming Presentation at AACR 2022
09 Mar 2022 //
BUSINESSWIRE
Boundless Bio to Present at the Oppenheimer 32nd Annual Healthcare Conference
08 Mar 2022 //
BUSINESSWIRE
Boundless Bio lures Berkley from Ionis to support clinical push
08 Feb 2022 //
FIERCEBIOTECH
Boundless Bio Appoints Peter Krein, Ph.D., as Vice President, Precision Medicine
17 Jan 2022 //
BUSINESSWIRE
Boundless Bio to Present at Piper Sandler & Evercore ISI HealthCONx Conference
17 Nov 2021 //
BUSINESSWIRE
Boundless Bio Appoints Jessica Oien as General Counsel and Corporate Secretary
30 Aug 2021 //
BUSINESSWIRE
Boundless Bio Appoints Neil Abdollahian as Chief Business Officer
09 Aug 2021 //
BUSINESSWIRE
Boundless Bio Announces Upcoming Presentation at the American Association
31 Mar 2021 //
BUSINESSWIRE
Boundless Bio Appoints Shailaja Kasibhatla as VP, D & T Development
18 Mar 2021 //
BUSINESSWIRE
